Trellus Health PLC
LSE:TRLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its Industry Average (0.3), the stock would be worth GBX-0.84 (661% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.1 | GBX0.15 |
0%
|
| Industry Average | 0.3 | GBX-0.84 |
-661%
|
| Country Average | 0.2 | GBX-0.58 |
-490%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| UK |
T
|
Trellus Health PLC
LSE:TRLS
|
483.5k GBP | -0.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
102.9B USD | 59.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
70.3B EUR | 13.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
75.1B USD | 12.8 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23B EUR | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.6B EUR | 22.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.7B USD | 20.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.3B USD | 23.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 10.9 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
10.9B USD | -26.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.1 |
| Median | 0.2 |
| 70th Percentile | 0.3 |
| Max | 828.3 |
Other Multiples
Trellus Health PLC
Glance View
Trellus Health Plc engages in the provision of digital chronic condition management solutions for employers and health plans. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2021-05-28. The firm is commercializing digital chronic condition management solutions for employers and health plans that utilize the scientifically validated Gaining Resilience Through Transitions (GRITT) resilience-based methodology and a proprietary HIPAA compliant technology platform called TrellusElevate, to coordinate and deliver personalized care remotely through telemedicine. The firm is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis.
